LM 10 - CAS 1316695-35-8
Catalog number: 1316695-35-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C11H8FN5
Molecular Weight:
229.21
COA:
Inquire
Targets:
TDO
Description:
Selective TDO inhibitor (IC50 values are 0.62 and 2 μM for human and mouse TDO, respectively)
Brife Description:
Selective TDO inhibitor (IC50 values are 0.62 and 2 μM for human and mouse TDO, respectively)
Purity:
> 98%
Appearance:
Off White solid
Synonyms:
6-Fluoro-3-[(1E)-2-(2H-tetrazol-5-yl)ethenyl]-1H-indole
Solubility:
Soluble to 100 mM in DMSO and to 20 mM in ethanol with gentle warming
Storage:
Store at -20°C
MSDS:
Inquire
Quality Standard:
In-house
Quantity:
Grams-Kilos
InChIKey:
FSGAFWYMLAWNJM-UHFFFAOYSA-N
InChI:
1S/C11H8FN5/c12-8-2-3-9-7(6-13-10(9)5-8)1-4-11-14-16-17-15-11/h1-6H,(H,14,17)(H,15,16)
Canonical SMILES:
C1=CC2=C(C=C1F)N=CC2=CC=C3NNN=N3
1.The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in vitro.
Kangwantas K;Pinteaux E;Penny J J Neuroinflammation. 2016 Feb 1;13:25. doi: 10.1186/s12974-016-0495-9.
BACKGROUND: ;The blood-brain barrier (BBB) of the central nervous system (CNS) is essential for normal brain function. However, the loss of BBB integrity that occurs after ischaemic injury is associated with extracellular matrix (ECM) remodelling and inflammation, and contributes to poor outcome. ECM remodelling also contributes to BBB repair after injury, but the precise mechanisms and contribution of specific ECM molecules involved are unknown. Here, we investigated the mechanisms by which hypoxia and inflammation trigger loss of BBB integrity and tested the hypothesis ECM changes could contribute to BBB repair in vitro.;METHODS: ;We used an in vitro model of the BBB, composed of primary rat brain endothelial cells grown on collagen (Col) I-, Col IV-, fibronectin (FN)-, laminin (LM) 8-, or LM10-coated tissue culture plates, either as a single monolayer culture or on Transwell® inserts above mixed glial cell cultures. Cultures were exposed to oxygen-glucose deprivation (OGD) and/or reoxygenation, in the absence or the presence of recombinant interleukin-1β (IL-1β). Cell adhesion to ECM molecules was assessed by cell attachment and cell spreading assays. BBB dysfunction was assessed by immunocytochemistry for tight junction proteins occludin and zona occludens-1 (ZO-1) and measurement of trans-endothelial electrical resistance (TEER).
2.A selective medium for recovery and enumeration of endolithic bacteria.
Bhattacharjee K;Joshi SR J Microbiol Methods. 2016 Oct;129:44-54. doi: 10.1016/j.mimet.2016.07.026. Epub 2016 Jul 30.
The study of lithic microbial communities, inhabiting rock substrates has been gathering momentum due to a growing attention of their wide importance as model systems in ecological studies and for their community structure. It is generally accepted that the success of cultivation-based technique is primarily based on suitable culture medium for isolation. The media available for enumeration and recovery of endolithic bacteria are mainly specific to particular type of rock which may not be suitable to isolate endolithic bacterial community from diverse lithobiontic niches. In this study, a new unoptimized medium was formulated, designated LM10 (unoptimized) for enumeration and recovery of endolithic bacteria by addition and/or omission of media components to the basal medium R2G, which was selected after experimental evaluation of five different existing media. The endolithic bacterial count in LM10 medium (unoptimized) was significantly higher than the R2G medium (t=-12.57, p<0.0001). The culture and nutritional parameters associated with unoptimized LM10 medium were optimized using statistical approach to maximize the recovery and enumeration of endolithic bacteria. The first phase of the study comprised of a Plackett-Burman (PB) design experiment conducted to screen thirteen medium components and two culture parameters as variables with effect on bacterial enumeration and recovery.
3.A cytochemical and immunocytochemical analysis of the wall labyrinth apparatus in leaf transfer cells in Elodea canadensis.
Ligrone R;Vaughn KC;Rascio N Ann Bot. 2011 Apr;107(4):717-22. doi: 10.1093/aob/mcr010. Epub 2011 Feb 2.
BACKGROUND AND AIMS: ;Transfer cells are plant cells specialized in apoplast/symplast transport and characterized by a distinctive wall labyrinth apparatus. The molecular architecture and biochemistry of the labyrinth apparatus are poorly known. The leaf lamina in the aquatic angiosperm Elodea canadensis consists of only two cell layers, with the abaxial cells developing as transfer cells. The present study investigated biochemical properties of wall ingrowths and associated plasmalemma in these cells.;METHODS: ;Leaves of Elodea were examined by light and electron microscopy and ATPase activity was localized cytochemically. Immunogold electron microscopy was employed to localize carbohydrate epitopes associated with major cell wall polysaccharides and glycoproteins.;KEY RESULTS: ;The plasmalemma associated with the wall labyrinth is strongly enriched in light-dependent ATPase activity. The wall ingrowths and an underlying wall layer share an LM11 epitope probably associated with glucuronoarabinoxylan and a CCRC-M7 epitope typically associated with rhamnogalacturonan I. No labelling was observed with LM10, an antibody that recognizes low-substituted and unsubstituted xylan, a polysaccharide consistently associated with secondary cell walls.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related TDO Products


RG7-0099

RG7-0099 is a small-molecule and dual inhibitor of IDO1/TDO (IDO1 IC50 < 100nM while TDO IC50 < 100nM) , which modulate immunosuppressive effects. In preclinica...

LM 10
(CAS: 1316695-35-8)

Selective TDO inhibitor (IC50 values are 0.62 and 2 μM for human and mouse TDO, respectively)

680C91
(CAS: 163239-22-3)

Potent and selective inhibitor of TDO (Ki = 51 nM).

Quick Inquiry

Verification code

Featured Items